As of 2025-07-13, the Intrinsic Value of Bright Minds Biosciences Inc (DRUG.CN) is -2.45 CAD. This DRUG.CN valuation is based on the model Peter Lynch Fair Value. With the current market price of 34.96 CAD, the upside of Bright Minds Biosciences Inc is -107.00%.
Based on its market price of 34.96 CAD and our intrinsic valuation, Bright Minds Biosciences Inc (DRUG.CN) is overvalued by 107.00%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -2.45 - -2.45 | -2.45 | -107.00% |
| P/E | 34.98 - 34.98 | 34.98 | 0.1% |
| DDM - Stable | (0.20) - (0.31) | (0.25) | -100.7% |
| DDM - Multi | (0.06) - (0.08) | (0.07) | -100.2% |
| Market Cap (mil) | 246.12 |
| Beta | 42.10 |
| Outstanding shares (mil) | 7.04 |
| Enterprise Value (mil) | 190.61 |
| Market risk premium | 5.10% |
| Cost of Equity | 163.52% |
| Cost of Debt | 5.00% |
| WACC | 163.44% |